| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.79B | +16.7% |
| Cost of Revenue | $1.77B | +12.7% |
| Gross Profit | $1.02B | +24.4% |
| R&D Expense | $190.7M | +16.3% |
| SG&A Expense | $476.4M | +10.9% |
| Operating Income | $249.3M | +22.0% |
| Pre-tax Income | -$55.0M | -36.6% |
| Income Tax | $18.9M | +123.2% |
| Net Income | -$73.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.6M | +20.8% |
| Inventory | $612.5M | +5.3% |
| Current Assets | $1.59B | +15.2% |
| Total Assets | $3.50B | +0.8% |
| Current Liabilities | $1.13B | +33.4% |
| Long-term Debt | $2.39B | -1.4% |
| Stockholders' Equity | -$109.3M | -652.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $295.1M | -14.6% |
| Capital Expenditures | $51.9M | +20.1% |
| Investing Cash Flow | -$63.0M | +9.0% |
| Financing Cash Flow | -$211.8M | +0.4% |
| Free Cash Flow | $243.2M | -19.6% |
| +6.8% |
| EPS (Basic) | -$0.38 | +20.8% |
| EPS (Diluted) | -$0.38 | +20.8% |